OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 26 filers reported holding OBALON THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $79,000 | -51.2% | 112,788 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $162,000 | -31.4% | 112,788 | -0.9% | 0.00% | -50.0% |
| Q4 2018 | $236,000 | -31.0% | 113,788 | -9.9% | 0.00% | 0.0% |
| Q3 2018 | $342,000 | +25.7% | 126,288 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $272,000 | -37.2% | 126,288 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $433,000 | – | 126,288 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|